AI nearly twice as good as biopsy at assessing rare cancer

AI could be nearly twice as accurate as biopsies at assessing the aggressiveness of some rare types of cancer, a new study suggests. According to researchers this could save the lives of thousands of patients. A research team from the Royal Marsden NHS Foundation Trust and the Institute for Cancer Research (ICR) focused on retroperitoneal sarcoma — a form of soft tissue sarcoma that develops in the back of the abdomen. “There is an urgent need to improve the diagnosis and treatment of patients with retroperitoneal sarcoma, who currently have poor outcomes,” said Dr Amani Arthur, first author of the…

This story continues at The Next Web https://thenextweb.com/news/ai-twice-as-good-biopsy-assessing-rare-cancer